Q4

Rossari Biotech Ltd

ROSSARIFY2525 Apr 2025

Revenue+13.0%

Net Profit+8.7%

OPM11.99%

P&L

Quarterly Consolidated

Revenue

+13.0%579.56

Expenditure

+13.3%533.79

Net Profit

+8.7%34.44

NPM 5.92%-3.1%EPS ₹6.22+8.6%

vs Q3 FY25

Informational and educational content only. Not investment advice.